Adherium (ASX:ADR) announced a data-based initiative with Summatix to allow clinicians to improve care of patients with asthma and chronic obstructive pulmonary disease across the world. New Zealand-based Adherium and Australia-based Summatix plan to build upon an existing relationship, as the former will gain access to Summatix’s platform to release data from its Hailie sensors for […]
Adherium Limited
ReShape Lifesciences CEO Gladney to resign | Personnel Moves – January 29, 2019
ReShape Lifesciences (NSDQ:RSLS) said yesterday that its prez & CEO Dan Gladney will resign from his positions with the company, effective March 31. Gladney will remain with the company as board chair, San Clemente, Calif.-based ReShape Lifesciences said. The company’s board of directors said they will immediately begin to look for a replacement, according to an […]
Adherium launches over-the-counter inhaler sensor in US
Adherium (ASK:ADR) today launched over-the-counter sales of its Hailie digital inhaler add-on in the U.S. The sensor is designed to integrate directly with prescription inhaler medications, sending adherence reminders and relevant data to a user’s smartphone to assist in managing chronic respiratory conditions like asthma and COPD. Get the full story at our sister site, Drug […]
Adherium looks to give doctors a window into their patients’ lives
To control an asthma patient’s symptoms, doctors will prescribe an inhaler to stop symptoms from cropping up and a rescue inhaler to be used if patients find themselves in the middle of an asthma attack. “But if your rescue inhaler doesn’t give you the relief that you need, your next recourse is to go to […]
FDA clears Adherium’s inhaler sensor for OTC sales
The FDA gave Adherium (ASK:ADR) the go-ahead to launch over-the-counter sales of its Smartinhaler sensor for AstraZeneca‘s (NYSE:AZN) Symbicort asthma inhaler, the company touted last week. Adherium’s product installs directly onto a patient’s inhaler to monitor and boost medication adherence. The device records the time and date that a patient uses their inhaler and transmits […]
Adherium to expand in U.S. market with direct-to-consumer push for smart inhaler tech
Adherium Ltd. (ASK:ADR), which sells a smart inhaler technology in Europe and Australia, is reportedly looking to jump into the direct-to-consumer U.S. market in the first half of this year. The New Zealand-based company has a deal with AstraZeneca (NYSE:AZN) to combine its Smartinhaler monitoring device with the Symbicort inhaler, but CEO Arik Anderson told MobiHealthNews that he is also looking for […]
Adherium wins 510(k) clearance for smart inhaler monitoring device
Adherium Ltd. (ASK:ADR) said today that it won 510(k) approval from the FDA for its inhaler monitoring device, SmartTouch for Symbicort. The device was cleared for use with AstraZeneca‘s (NYSE:AZN) Symbicort aerosol inhaler. The Melbourne, Australia-based company’s product installs directly onto a patient’s inhaler to monitor and boost medication adherence. Get the full story at our sister […]
GE Healthcare CEO Flannery promoted to GE’s corner office | Personnel Moves – June 12, 2017
Former GE Healthcare (NYSE:GE) head John Flannery will be stepping into the corner office for all of GE, replacing Jeff Immelt who is stepping aside after 16 years as head of the large conglomerate. The CEO transition will go into effect Aug. 1, while Flannery will also take over as board chair after Immelt retires on […]
Collecting purposeful data in the era of connected health devices
Connectivity, one of the newest buzzwords in the medical device lexicon, is becoming more and more integral to device design and development. Research shows that connected health devices can improve patient outcomes by increasing adherence and reducing dosing variability. Mark David Tuckwell, head of electronics, software & systems at Sagentia, says connected device can also provide crucial information to help […]
Adherium’s smart inhaler tech chosen for EU mobile health program
Adherium Ltd. (ASK:ADR) said today that its Smartinhaler was chosen for the myAirCoach program as a part of the European Union’s Horizon 2020 Framework for Research and Innovation. The Horizon 2020 program is the largest EU research and innovation program ever established, with €80 billion (nearly $85 billion) of funding available from 2014 until 2020. The […]
Adherium touts Smartinhaler asthma study
Adherium (ASK:ADR) touted data from an independent study of its Smartinhaler respiratory disease management tool in children with poorly controlled asthma. The STAAR study was conducted at Sheffield Children’s Hospital in the UK and the results were published this month in Thorax. The New Zealand-based company found that in children with poorly controlled asthma, introducing its […]